• The European Circular Bioeconomy Fund (ECBF) expands Aphea.Bio Series B funding round to EUR 18 million

    Wednesday April 14th 2021

  • Confo Therapeutics awarded EUR 1M VLAIO grant for pre-clinical development of CFTX-1554

    Wednesday March 31st 2021

  • Augustine Therapeutics awarded EUR 1.2 million VLAIO research grant to develop new medicines for neuromuscular diseases

    Tuesday March 23rd 2021

  • AgomAb Therapeutics kondigt $74 miljoen series-B financiering aan

    Wednesday March 10th 2021

  • Rejuvenate Biomed secures EUR 3.2 million series A round to advance development of healthy aging products

    Tuesday March 2nd 2021

  • Newton Biocapital invests in Flemish start-up DeuterOncology

    Wednesday February 24th 2021

  • QBD leerstoel voor precision oncology research in glioblastoma

    Wednesday February 17th 2021

  • Grapheal raises EUR1.9 million to advance development of embedded biosensing technology and application in digital COVID testing and wound monitoring

    Wednesday February 10th 2021

  • Your news here?

  • V-Bio Ventures launches its second fund at EUR 78 million

    Thursday February 4th 2021

  • Euronext Biotech Barometer H2 2020

    Monday February 1st 2021

  • reMYND extends Series B funding to EUR 24 million

    Thursday January 21st 2021

Strategic Partners